Monotherapy versus combination therapy of statin and renin–angiotensin system inhibitor in ST-segment elevation myocardial infarction

BACKGROUND: The beneficial effects of statin and renin–angiotensin system inhibitor (RASI) are well-known. In this retrospective cohort study, 2-year clinical outcomes were compared between monotherapy and combination therapy with statin and RASI in ST-segment elevation myocardial infarction (STEMI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Hoon, Her, Ae-Young, Jeong, Myung-Ho, Kim, Byeong-Keuk, Hong, Sung-Jin, Kim, Seunghwan, Ahn, Chul-Min, Kim, Jung-Sun, Ko, Young-Guk, Choi, Donghoon, Hong, Myeong-Ki, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890409/
https://www.ncbi.nlm.nih.gov/pubmed/32207841
http://dx.doi.org/10.5603/CJ.a2020.0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890409/
https://www.ncbi.nlm.nih.gov/pubmed/32207841
http://dx.doi.org/10.5603/CJ.a2020.0035

Ejemplares similares